Elios Therapeutics
PrivateLast Round
Seed
Sep 10, 2015
Total Funding Raised
$2.39M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Elios Therapeutics is a biopharmaceutical company that develops personalized therapeutic cancer vaccines for the treatment of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elios Therapeutics Comparables
Compare Elios Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AiVita Biomedical | 81% | |
| Northwest Biotherapeutics Inc | 73% | |
| Moderna, Inc. | 73% |
Elios Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 10, 2015 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- May 24, 2026
Grew 150% QoQ, from 2 to 5 employees.
Elios Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Elios Therapeutics's valuation, stock price, and market status.
Is Elios Therapeutics a public or private company?
Elios Therapeutics is a private company.
What is the current stock price of Elios Therapeutics?
Elios Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Elios Therapeutics worth (valuation)?
Valuation information for Elios Therapeutics is not publicly available.
Can I buy Elios Therapeutics stock?
Elios Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Elios Therapeutics's last funding round?
Elios Therapeutics's most recent funding round was Seed on September 10, 2015.
Who are the main investors in Elios Therapeutics?
Investor information for Elios Therapeutics is not publicly disclosed.
Will Elios Therapeutics IPO soon?
No public IPO plans have been announced for Elios Therapeutics.
How can I track Elios Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Elios Therapeutics's secondary market activity and sign up for updates.